Mendra
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $82M
Investors
- 5
About Mendra
Mendra Therapeutics operates in the rare disease sector, focusing on therapeutic development.Mendra Therapeutics specializes in developing innovative therapeutics for rare and ultra-rare diseases, leveraging artificial intelligence to expedite clinical development and commercialization processes. The company's core offerings include advanced biopharmaceutical products designed to address significant unmet medical needs. Its products primarily serve patients diagnosed with rare diseases and their families, as well as healthcare providers involved in treatment.Mendra Therapeutics generates revenue through strategic partnerships and collaborations with research and development-stage biotech companies, focusing on high-potential therapies. The firm's transaction structure typically involves licensing agreements and co-development partnerships, allowing for shared risk in advancing therapeutics to market. The company may also engage in direct-to-consumer sales for select products, providing access to life-saving treatments. The strategy includes upcoming product launches designed to cater to patients with high unmet needs, alongside expansion into additional geographic regions, including strategic markets in Europe and Asia, expected to occur within the next two years.
Who invested in Mendra
5 investors across 1 round
See all investors in Mendra
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 21, 2026
Amount
$82M
Investors
Questions about Mendra
Who invested in Mendra?
Mendra has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mendra raised?
Mendra has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mendra last raise money?
Mendra's most recent round on record is a Series A, in Jan 2026.
What does Mendra do?
Mendra Therapeutics operates in the rare disease sector, focusing on therapeutic development.
Where is Mendra headquartered?
Mendra is headquartered in San Francisco, US.
Which VCs invest in companies like Mendra?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mendra's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mendra? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.